Get the Daily Brief
Latest Biotech News
Alliance Scales Data-Driven Type 1 Diabetes Care
The Rising T1DE Alliance has expanded with the addition of Ann & Robert H. Lurie Children’s Hospital, supported by a $5.1 million grant from the Helmsley Charitable Trust. The alliance is...
Novel Breast Cancer Drug Targeting VIPR2 Dimerization
Researchers at Hiroshima University have identified a promising breast cancer therapeutic target involving vasoactive intestinal peptide receptor-2 (VIPR2) dimerization. Their study shows that...
FDA Expands Moderna’s RSV Vaccine Indications
The U.S. FDA has broadened the approved use of Moderna’s mRESVIA vaccine for respiratory syncytial virus (RSV) to include at-risk adults aged 18 and older. This regulatory action follows closely...
Extensive Optical Clock Network Advances Timekeeping
A multinational collaboration conducted the largest coordinated comparison of optical clocks, operating clocks and frequency links simultaneously across six countries. These measurements,...
UroGen’s Bladder Cancer Hydrogel Gains FDA Approval
Despite a narrowly negative advisory panel vote, the FDA approved UroGen Pharma’s intravesical hydrogel treatment, Zusduri (mitomycin), for low-grade, intermediate-risk non-muscle invasive bladder...
BioNTech Acquires CureVac to End Patent Dispute
BioNTech announced an all-stock deal valued at $1.25 billion to acquire German mRNA vaccine developer CureVac. This acquisition consolidates mRNA manufacturing and cancer immunotherapy assets,...
Wellcome Sanger and Partners Create Cancer Plasticity Atlas
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have launched a collaborative effort to build a comprehensive single-cell atlas capturing cancer cell plasticity and...
Optical clock network sets foundation for redefining the second
An unprecedented international coordination of optical clocks spanning six countries demonstrated precise frequency comparisons essential for redefining the second. This technical milestone moves...
Brain implant enables expressive speech and singing in ALS patient
A brain-computer interface neurosynthesizer enabled a man with severe speech impairment to communicate with his own voice and expressively sing, marking a breakthrough in assistive communication...
ADC Therapeutics shutters UK R&D, cuts workforce 30%
Swiss biotech ADC Therapeutics announced the closure of its U.K. research site, discontinuation of certain solid tumor programs, and a workforce reduction of 30%. These steps follow the...
Optical clock breakthrough: Redefining the second globally
A major multinational study spearheaded by researchers from the National Physical Laboratory and Instituto Nazionale Di Ricerca Metrologica has coordinated optical clocks spanning six countries to...
FDA approves bladder cancer hydrogel amid advisory conflicts
Urogen Pharma secured FDA approval for Zusduri (mitomycin) to treat recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer after a narrowly negative advisory committee vote. The...
Trump administration demands pharma start drug price talks
The Trump administration is pressing pharmaceutical companies to begin negotiations aimed at aligning U.S. drug prices with those of comparable economies, which are generally lower. The Department...
AI neuroprosthesis restores expressive speech for ALS patient
Researchers have demonstrated a brain-computer interface that decodes neural signals to generate synthesized speech with paralinguistic features such as tone and melody in real time. Implanted...
BioNTech acquires CureVac to end mRNA patent battle
BioNTech announced a $1.25 billion all-stock acquisition of German biotech CureVac, resolving ongoing messenger RNA patent disputes. CureVac's shareholders will receive BioNTech shares valued at a...
Rice University improves CO₂-to-fuel conversion stability
A Rice University team developed a method using acid-humidified CO₂ to prevent salt accumulation that disrupts gas flow in electrochemical systems converting carbon dioxide into fuels. This...
New soft bioelectronics enable embryonic brain activity mapping
Harvard bioengineers designed ultrathin, flexible mesh microelectrode arrays that integrate seamlessly into the developing neural plate of tadpole embryos. This innovative implant expands...
NK cell sensitivity boost offers new cancer immunotherapy avenue
Researchers at Monash University and oNKo-Innate identified a gene whose inhibition in natural killer (NK) cells amplifies their sensitivity to IL-15, an immune growth factor imperative for cancer...
Med-tech firm Agilent launches advanced LC-MS systems
Agilent Technologies introduced the InfinityLab Pro iQ Series, a new generation of liquid chromatography-mass spectrometry platforms designed for pharmaceutical, biopharmaceutical, and...
Glycosaminoglycan-driven lipoprotein uptake shields tumors
A study revealed that cancer cells utilize sulfated glycosaminoglycans on their surface to mediate uptake of lipoproteins carrying α-tocopherol, a form of vitamin E that inhibits ferroptosis, an...